Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults
Xiaoqiang Liu, Yuhua Li, Zhongfang Wang, Shouchun Cao, Weijin Huang, Lin Yuan, Yi-Jiao Huang, Yan Zheng, Jingjing Chen, Bo Ying, Zuoyun Xiang, Jin Shi, Jincun Zhao, Zhen Huang, View ORCID ProfileCheng-Feng Qin
doi: https://doi.org/10.1101/2022.05.30.22275753
Xiaoqiang Liu
1Yunnan Province Centre for Disease Control and Prevention, Kunming, Yunnan, China
Yuhua Li
2National Institutes for Food and Drug Control, Beijing, China
Zhongfang Wang
3Respiratory Medicine, Guangzhou Institute of Respiratory Health, Guangzhou, Guangdong, China
Shouchun Cao
2National Institutes for Food and Drug Control, Beijing, China
Weijin Huang
2National Institutes for Food and Drug Control, Beijing, China
Lin Yuan
4Walvax Biotechnology Co., Ltd., Kunming, Yunnan China
Yi-Jiao Huang
5State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, China
Yan Zheng
1Yunnan Province Centre for Disease Control and Prevention, Kunming, Yunnan, China
Jingjing Chen
4Walvax Biotechnology Co., Ltd., Kunming, Yunnan China
Bo Ying
6Suzhou Abogen Biosciences Co., Ltd., Suzhou, Jiangsu, China
Zuoyun Xiang
4Walvax Biotechnology Co., Ltd., Kunming, Yunnan China
Jin Shi
4Walvax Biotechnology Co., Ltd., Kunming, Yunnan China
Jincun Zhao
3Respiratory Medicine, Guangzhou Institute of Respiratory Health, Guangzhou, Guangdong, China
Zhen Huang
4Walvax Biotechnology Co., Ltd., Kunming, Yunnan China
Cheng-Feng Qin
5State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, China
7Research Unit of Discovery and Tracing of Natural Focus Diseases, Chinese Academy of Medical Sciences, Beijing, China
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted May 31, 2022.
Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults
Xiaoqiang Liu, Yuhua Li, Zhongfang Wang, Shouchun Cao, Weijin Huang, Lin Yuan, Yi-Jiao Huang, Yan Zheng, Jingjing Chen, Bo Ying, Zuoyun Xiang, Jin Shi, Jincun Zhao, Zhen Huang, Cheng-Feng Qin
medRxiv 2022.05.30.22275753; doi: https://doi.org/10.1101/2022.05.30.22275753
Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults
Xiaoqiang Liu, Yuhua Li, Zhongfang Wang, Shouchun Cao, Weijin Huang, Lin Yuan, Yi-Jiao Huang, Yan Zheng, Jingjing Chen, Bo Ying, Zuoyun Xiang, Jin Shi, Jincun Zhao, Zhen Huang, Cheng-Feng Qin
medRxiv 2022.05.30.22275753; doi: https://doi.org/10.1101/2022.05.30.22275753
Subject Area
Subject Areas
- Addiction Medicine (400)
- Allergy and Immunology (711)
- Anesthesia (202)
- Cardiovascular Medicine (2954)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12764)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4599)
- Geriatric Medicine (420)
- Health Economics (730)
- Health Informatics (2934)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (925)
- Medical Education (427)
- Medical Ethics (116)
- Nephrology (470)
- Neurology (4373)
- Nursing (237)
- Nutrition (640)
- Oncology (2277)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1197)
- Primary Care Research (499)
- Public and Global Health (6963)
- Radiology and Imaging (1532)
- Respiratory Medicine (915)
- Rheumatology (440)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (181)